DDI in collaboration with Sanofi, hosted a two-day training workshop titled “Fundamentals of Clinical Research and Good Clinical Practice” in the Courtyard Marriott. This workshop was delivered by the Brookwood International Academy on February 18-19, 2019.
Brookwood International Academy of Healthcare Research aims to provide excellence in clinical-based research and good clinical practice (GCP). By developing a workshop centered around clinical research and clinical trials, participants will learn how to setup clinical trials and the importance of understanding and complying with GCP during this process.
This course was conducted for healthcare professionals working in the Ministry of Health, who care to improve research quality and patient outcomes. It involved interactive presentations and exercises and qualified participants for the optional examination for the Certificate in Clinical Research and GCP. GCP is a pre-requisite to conducting any clinical trial.
Dr Ebaa AlOzairi: “Such courses targeting any healthcare professional are fundamental for good clinical practice. We look forward to future collaborations and advanced courses to improve clinical research practices.”
“At Sanofi, we are pleased to partner with Dasman Diabetes Institute to further our commitment towards improving patient lives and contributing to the growth of healthy societies. Through this workshop, we aim to empower the scientific community in Kuwait by equipping them with the highest standards of skills and expertise in clinical research. Our endeavor is to advance and encourage scientific thinking, which can drive the best results for maximum patient benefit,” said Jean-Paul Scheuer, Country Chair and General Manager for Sanofi Gulf.
DDI and Sanofi signed a Memorandum of Understanding (MoU) last year, with the first cooperation being the World Diabetes Day in November 16, 2018. The MoU provides for continued strengthening of future collaborations between the Sanofi and DDI in achieving common goals, fostering education, and encouraging innovative research.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.